INTRASTRIATAL IMPLANTS OF POLYMER ENCAPSULATED CELLS GENETICALLY-MODIFIED TO SECRETE HUMAN NERVE GROWTH-FACTOR - TROPHIC EFFECTS UPON CHOLINERGIC AND NONCHOLINERGIC STRIATAL NEURONS
Jh. Kordower et al., INTRASTRIATAL IMPLANTS OF POLYMER ENCAPSULATED CELLS GENETICALLY-MODIFIED TO SECRETE HUMAN NERVE GROWTH-FACTOR - TROPHIC EFFECTS UPON CHOLINERGIC AND NONCHOLINERGIC STRIATAL NEURONS, Neuroscience, 72(1), 1996, pp. 63-77
Nerve growth factor selectively prevents the degeneration of cholinerg
ic neurons following intrastriatal infusion but rescues both cholinerg
ic and noncholinergic striatal neurons if the nerve growth factor is s
ecreted from grafts of genetically modified fibroblasts. The present s
tudy evaluated whether grafted fibroblasts genetically modified to sec
rete human nerve growth factor could provide trophic influences upon i
ntact cholinergic and noncholinergic striatal neurons. Unilateral stri
atal grafts of polymer-encapsulated cells genetically modified to secr
ete human nerve growth factor induced hypertrophy and significantly in
creased the optical density of choline acetyltransferase-immunoreactiv
e striatal neurons one, two, and four weeks post-transplantation relat
ive to rats receiving identical grafts missing only the human nerve gr
owth Factor construct. Nerve growth factor secreting grafts also induc
ed a hypertrophy of noncholinergic neuropeptide Y-immunoreactive stria
tal neurons one, two, and four weeks post-transplantation. Glutamic ac
id decarboxylase-immunoreactive neurons were unaffected by the human n
erve growth factor secreting grafts. The effects upon choline acetyltr
ansferase-immunoreactive and neuropeptide Y-immunoreactive striatal ne
urons dissipated following retrieval of the implants. Immunocytochemis
try for nerve growth factor revealed intense graft-derived immunoreact
ivity for up to 1000 mu m from the capsule extending along the dorsove
ntral axis of the striatum. Nerve growth factor-immunoreactivity was a
lso observed within a subpopulation of striatal neurons and may repres
ent nerve growth Factor consumer neurons which retrogradely transporte
d graft-derived nerve growth factor. When explanted, grafts produced 2
-4 ng human nerve growth factor/24 h over the time course of this stud
y indicating that this level of continuous human nerve growth factor s
ecretion was sufficient to mediate the effects presently observed.